News

$1million award to Harveer Dev and team

1 February 2023

Congratulations to Dr Harveer Dev and a team from the University of Cambridge and the Knight Cancer Institute at OHSU who have been awarded a $1 million Challenge grant by the Prostate Cancer Foundation for their project entitled First-In-Man PARP1-selective inhibitor in lethal prostate cancer: mechanisms of action and...

Caroline Watson awarded Milo Keynes thesis prize

31 January 2023

Congratulations to Dr Caroline Watson, CRUK-funded Clinical Research Fellow (2017-2021) in the Blundell lab , who has been awarded the prestigious Milo Keynes prize by the University of Cambridge School of Clinical Medicine for the outstanding quality of her PhD thesis. Caroline's thesis was entitled The evolutionary...

Representation of proposed Cambridge Cancer Research Hospital

Planning permission submitted for East of England cancer hospital

26 January 2023

A full planning application to build a new specialist cancer research hospital for the region on the Cambridge Biomedical Campus has been submitted to Cambridge City Council. The new Cambridge Cancer Research Hospital (CCRH) will change the story of cancer. It will bring together clinical and research expertise in a new-world class hospital for the East of England to detect cancer earlier, treat it more precisely and save more lives.

DNA graffiti: mutation patterns in cancer - watch the Francis Crick Lecture given by Serena Nik-Zainal

18 January 2023

Professor Serena Nik-Zainal was awarded the Francis Crick Medal in 2022 and recently gave the prize lecture at the Royal Society. In the lecture, she explains that human cancers are highly individual. Etched into the DNA of cancers are graffiti-like mutation patterns, which could reveal underlying biological abnormalities, unique to each person’s cancer, with potential for application in precision medicine. You can watch the full lecture on the Royal Society YouTube channel.

Understanding is in the mind of the beholder - communicating cancer risk across different audiences

17 January 2023

The background that led to the development of the new Massive Open Online Course (MOOC) in risk communication from the CRUK Cambridge Centre is fascinating and, like many good things, arose almost accidentally out of adversity.

Prostate cancer risk prediction algorithm could help target testing at men at greatest risk

9 December 2022

Prostate cancer is the most common type of cancer in men. According to Cancer Research UK, over 52,000 men are diagnosed with the disease each year and there are more than 12,000 deaths. Now, Cambridge scientists have created a new, comprehensive tool for predicting an individual’s risk of developing prostate cancer, which they say could help ensure that those men at greatest risk will receive the appropriate testing while reducing unnecessary – and potentially invasive – testing for those at very low risk.

Rebecca Fitzgerald receives Innovation and Entrepreneurship award

Rebecca Fitzgerald receives Cancer Research Horizons Innovation and Entrepreneurship Award

7 December 2022

Congratulations to Early Cancer Institute Director, Professor Rebecca Fitzgerald, who has been awarded an Impact Recognition Award by Cancer Research Horizons. The awards recognise the UK’s most innovative and enterprising efforts in oncology. The judges of the Impact Recognition Award were looking for evidence of...

Early career researchers successfully awarded ACED funding

14 November 2022

Two early career researchers from the University of Cambridge have been awarded ACED Early Career Pathway awards in the latest round of funding announced by CRUK’s International Alliance for Cancer Early Detection (ACED).

EU cancer screening recommendations 2022

Screening more and screening better: New recommendations for cancer screening published by European Union

5 October 2022

Extended access to existing screening programmes and introduction of three new screening programmes are the recommendations made in the final report from the European Commission’s group of Chief Scientific Advisors, co-chaired by Early Cancer Institute Director Professor Rebecca Fitzgerald. The proposed Recommendation...

Harvey Dev awarded grant extension to further prostate cancer research

4 October 2022

Congratulations to Dr Harveer Dev who has been awarded a grant extension by Prostate Cancer Research to develop his new ProCASP tool, a CRISPR-Cas9 dynamic screening platform for prostate cancer.

$1million award to Harveer Dev and team

Caroline Watson awarded Milo Keynes thesis prize

Planning permission submitted for East of England cancer hospital

DNA graffiti: mutation patterns in cancer - watch the Francis Crick Lecture given by Serena Nik-Zainal

Understanding is in the mind of the beholder - communicating cancer risk across different audiences

Prostate cancer risk prediction algorithm could help target testing at men at greatest risk

Rebecca Fitzgerald receives Cancer Research Horizons Innovation and Entrepreneurship Award

Early career researchers successfully awarded ACED funding

Screening more and screening better: New recommendations for cancer screening published by European Union

Harvey Dev awarded grant extension to further prostate cancer research

Upcoming events

Contact Us

Quick Links

Connect with us

Study at Cambridge

About the University

Research at Cambridge